$2.400
-0.114 (-4.76%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
CMPX Prediction & Forecast by Similar Chart Analysis
Alphio's CMPX stock price prediction model matches the current Compass Therapeutics Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.39 (-0.50%). The 1-week path is $2.43 (+1.28%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Compass Therapeutics Inc. Stock?
Compass Therapeutics Inc. is a good buy right now due to its current price of $2.40, which is significantly lower than the analyst price target of $7, indicating a potential upside of over 200%. Additionally, the company has a strong cash position of $195 million, providing a runway until 2028, which supports its operational stability despite ongoing losses. However, the main risk is its negative earnings per share (EPS) of -0.13 reported in the latest quarter, indicating continued financial challenges.
CMPX stock price ended at $2.40 on Friday, after losing -4.76%
Compass Therapeutics Inc. (CMPX) last closed at $2.4, losing -4.76%. These facts feed the 1-day and 1-week CMPX price prediction above.
Forecast Drivers
Compass Therapeutics Inc. (CMPX) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches CMPX, ranked by similarity.
Seasonality analysis for CMPX
Historically the probability of a positive August return for CMPX is 34.92%. October offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for CMPX
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.20 | $2.68 | $2.92 | +11.56% |
| Sep 2026 | $3.44 | $3.62 | $4.27 | +50.94% |
| Oct 2026 | $2.83 | $3.31 | $3.83 | +37.95% |
| Nov 2026 | $3.15 | $3.62 | $4.07 | +50.94% |
| Dec 2026 | $2.28 | $2.70 | $2.75 | +12.47% |
In 2026, Compass Therapeutics Inc. (CMPX) is projected to range from $2.20 to $4.27.
Compass Therapeutics Inc. 2026 monthly forecast
In Aug 2026, Compass Therapeutics Inc. is projected to average $2.68, with a low of $2.20 and high of $2.92.
In Sep 2026, Compass Therapeutics Inc. is projected to average $3.62, with a low of $3.44 and high of $4.27.
In Oct 2026, Compass Therapeutics Inc. is projected to average $3.31, with a low of $2.83 and high of $3.83.
In Nov 2026, Compass Therapeutics Inc. is projected to average $3.62, with a low of $3.15 and high of $4.07.
In Dec 2026, Compass Therapeutics Inc. is projected to average $2.70, with a low of $2.28 and high of $2.75.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.